Related Experiment Video
Updated: Jun 27, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
Published on: July 19, 2024
Advances in Non-Alcoholic Fatty Liver Disease: Pathophysiology, Diagnosis, and Emerging Therapies
Ioannis Katsaros1, Dimitrios Schizas1
1First Department of Surgery, Laikon General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Abstract:
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as one of the most pressing public health challenges, affecting more than 30% of the global adult population and projected to exceed 55% prevalence by 2040 [...].
Related Concept Videos
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction
Chronic Pancreatitis II: Pathophysiology
Cirrhosis II: Pathophysiology
Chronic Pancreatitis I: Introduction
